Utah Medical Profit Margin vs. EBITDA

UTMD Stock  USD 63.84  0.10  0.16%   
Taking into consideration Utah Medical's profitability measurements, Utah Medical Products may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Utah Medical's ability to earn profits and add value for shareholders.

Utah Medical Net Profit Margin

0.33

As of December 9, 2024, Price To Sales Ratio is expected to decline to 3.45. In addition to that, Days Sales Outstanding is expected to decline to 23.05. At present, Utah Medical's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Non Operating Income Net Other is expected to grow to about 251.2 K, whereas Operating Income is forecasted to decline to about 11.7 M.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.440.5981
Way Down
Pretty Stable
Net Profit Margin0.20.3312
Way Down
Slightly volatile
Operating Profit Margin0.250.334
Way Down
Very volatile
Pretax Profit Margin0.270.4
Way Down
Slightly volatile
Return On Assets0.210.1228
Way Up
Slightly volatile
Return On Equity0.120.1296
Significantly Down
Slightly volatile
For Utah Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Utah Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Utah Medical Products utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Utah Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Utah Medical Products over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
1.2
Earnings Share
4.28
Revenue Per Share
12.392
Quarterly Revenue Growth
(0.20)
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Utah Medical Products EBITDA vs. Profit Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Utah Medical's current stock value. Our valuation model uses many indicators to compare Utah Medical value to that of its competitors to determine the firm's financial worth.
Utah Medical Products is rated first in profit margin category among its peers. It is rated fifth in ebitda category among its peers totaling about  71,496,245  of EBITDA per Profit Margin. At present, Utah Medical's Net Profit Margin is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Utah Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Utah EBITDA vs. Profit Margin

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Utah Medical

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
0.35 %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Utah Medical

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
24.75 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Utah EBITDA Comparison

Utah Medical is currently under evaluation in ebitda category among its peers.

Utah Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Utah Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Utah Medical will eventually generate negative long term returns. The profitability progress is the general direction of Utah Medical's change in net profit over the period of time. It can combine multiple indicators of Utah Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-10.7 M-10.1 M
Operating Income16.8 M11.7 M
Income Before Tax20.1 M13 M
Net Income16.6 M10.1 M
Income Tax Expense3.5 M3.8 M
Total Other Income Expense Net3.3 M3.5 M
Net Income Applicable To Common Shares18.9 M11.8 M
Net Income From Continuing Ops16.9 M16.8 M
Non Operating Income Net Other239.2 K251.2 K
Interest Income292.1 K306.7 K
Change To Netincome-163.8 K-172 K
Net Income Per Share 4.57  4.80 
Income Quality 1.34  1.02 
Net Income Per E B T 0.83  0.58 

Utah Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Utah Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Utah Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Utah Medical's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Utah Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Use Investing Themes to Complement your Utah Medical position

In addition to having Utah Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Railroads Thematic Idea Now

Railroads
Railroads Theme
Companies involved in manufacturing and maintenance of freight railroads and passenger trains as well as providing railroad services to public. The Railroads theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Railroads Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:
Check out World Market Map.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
To fully project Utah Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Utah Medical Products at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Utah Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Utah Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Utah Medical investors may work on each financial statement separately, they are all related. The changes in Utah Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Utah Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.